Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role
Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.
Related Resources
Letter/Comment
The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy…
White Papers
Explore opportunities for improving the procure-to-pay cycle to generate better outcomes for both health care organizations and their supplier…
e-Learning
The Introduction to Health Care Supply Chain eLearning courses provide grounded education for those new or seeking a refresher.
e-Learning
This advanced course leads learners through 10 areas of infrastructure surrounding the functions of health care supply chain management.
Guides/Reports
The UDI-DI Change Communication Process Work Group, a part of AHRMM's Learning UDI Community (LUC), recently released a report analyzing current…
Guides/Reports
The UDI Impacts on Recall Management Work Group, a part of AHRMM's Learning UDI Community (LUC), has released their recommended practices reports…